Business
Director Declaration
Spire Healthcare Group plc announced that Non-Executive Director Jill Anderson will join the board of Croda International Plc as a Non-Executive Director effective 12 January 2026, also becoming a member of Croda's Audit, Nomination, and Remuneration committees. No further disclosures are required under UKLR 6.4.9R. Disclaimer*
About this update from Spire Healthcare Group Plc
[{"type":"text","content":"\n\nSpire Healthcare Group plc\n \nDirector Declaration\n \n \n9 January 2026\n \nSpire Healthcare Group plc (LSE: SPI) ('Spire Healthcare', 'the Group' or 'the Company'), a leading independent healthcare group in the UK, announces that Jill Anderson, a Non-Executive Director of the Company, has been appointed as a Non-Executive Director of Croda International Plc. Jill will join the board of Croda International Plc on 12 January 2026 and become a member of the Audit, Nomination and Remuneration committees.\n \nThere are no further disclosures required for the purposes of UKLR 6.4.9R.\n \n \nFor further information please contact:\n \n\n\n\n\nSpire Healthcare Group plc\nAmie Gramlick, Director of Commercial Finance & Investor Relations\n\n\n+44 (0)80 0169 1777\n\n\n\n\nBrunswick (Communications adviser)\nSimon Sporborg / Ayesha Bharmal\n\n\n+44 (0)20 7404 5959\n\n\n\n\n \n \nAbout Spire\nSpire is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.\n \nWorking in partnership with over 8,700 experienced consultants, Spire delivered tailored, personalised care to over one million inpatients, outpatients and daycase patients, and occupational health programme clients, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.\n \nSpire's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and private medical insurance ('PMI') providers. 98% of Spire's inspected locations are rated 'Good,' 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.\n \nSpire is listed on the London Stock Exchange and is a member of the FTSE 250.\n\n","length":4411,"tagName":"div"}]